Research Article
Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal
Table 3
Univariable and multivariable Cox analysis of prognostic factors for disease free survival in 503 patients with esophageal squamous cell carcinoma.
| | Univariable analysis | Multivariable analysis | HR (95% CI) | value | HR (95% CI) | value |
| Age, year | 1.01 (0.99-1.02) | 0.17 | | | Sex | | | | | Male | Ref | | | | Female | 0.75 (0.54-1.02) | 0.07 | | | BMI, kg/m2 | 0.97 (0.94-1.01) | 0.20 | | | Tobacco use | | | | | No | Ref | | | | Yes | 1.07 (0.84-1.36) | 0.60 | | | Alcohol use | | | | | No | Ref | | | | Yes | 1.12 (0.86-1.45) | 0.42 | | | Comorbidities | | | | | History of hypertension | | | | | No | | | | | Yes | 1.11 (0.87-1.41) | 0.42 | | | History of diabetes | | | | | No | Ref | | | | Yes | 1.26 (0.96-1.64) | 0.09 | | | History of COPD | | | | | No | Ref | | Ref | | Yes | 1.42 (1.02-1.97) | 0.04 | 1.65 (1.17-2.31) | 0.004 | History of hepatitis | | | | | No | Ref | | | | Yes | 0.96 (0.69-1.33) | | | | History of cardiovascular disease | | | | | No | Ref | | | | Yes | 0.91 (0.66-1.26) | | | | Preoperative albumin | 0.96 (0.93-0.99) | 0.04 | | | Preoperative platelet, 109 | 1.001 (0.999-1.003) | 0.436 | | | Preoperative WBC, 109 | 1.05 (0.99-1.12) | 0.08 | | | Preoperative NLR | 1.05 (0.99-1.11) | 0.05 | | | Length of tumor, cm | 1.17 (1.11-1.25) | <0.001 | | | Location of tumor | | | | | Upper | Ref | | | | Middle | 0.85 (0.62-1.17) | 0.33 | | | Lower | 0.93 (0.65-1.35) | 0.71 | | | Differentiation of tumor | | | | | Well | Ref | | | | Moderate | 1.62 (1.07-2.46) | 0.02 | | | Poor | 2.04 (1.31-3.18) | 0.002 | | | Pathological T stage | | | | | T1 | Ref | | Ref | | T2 | 2.92 (1.67-5.09) | <0.001 | 2.21 (1.25-3.89) | 0.006 | T3 | 5.23 (3.08-8.89) | <0.001 | 3.46 (2.00-5.97) | <0.001 | T4 | 6.42 (3.48-11.82) | <0.001 | 3.47 (1.82-6.60) | <0.001 | Pathological N factor | | | | | N0 | Ref | | Ref | | N1 | 2.09 (1.58-2.78) | <0.001 | 1.65 (1.30-2.49) | 0.002 | N2 | 3.72 (2.37-5.84) | <0.001 | 2.20 (1.27-3.79) | 0.005 | N3 | 5.11 (3.68-7.09) | <0.001 | 3.20 (2.07-4.93) | <0.001 | Pathological stage | | | | | I | Ref | | | | II | 2.80 (1.63-4.81) | <0.001 | | | III | 7.23 (4.19-12.46) | <0.001 | | | IV | 7.02 (3.96-12.45) | <0.001 | | | Number of dissected LNs | 1.01 (0.99-1.02) | 0.28 | | | Number of positive LNs | 1.13 (1.10-1.17) | <0.001 | | | Rate of positive LNs | 9.19 (5.8-14.58) | <0.001 | 1.99 (0.90-4.36) | 0.009 | Postoperative complications | | | | | Postoperative pulmonary complications | 1.21 (0.94-1.56) | 0.14 | | | Postoperative anastomotic leakage | 1.44 (0.88-2.35) | 0.15 | | | Postoperative cardiovascular disease | 1.11 (0.84-1.47) | 0.46 | | | Sepsis | 1.66 (1.07-2.57) | 0.02 | 1.79 (1.16-2.79) | 0.009 |
|
|
BMI: body mass index; COPD: chronic obstructive pulmonary disease; NLR: neutrophil to lymphocyte ratio.
|